Original Article
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Sep 24, 2014; 4(3): 188-195
Published online Sep 24, 2014. doi: 10.5500/wjt.v4.i3.188
Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type
Kalathil K Sureshkumar, Sabiha M Hussain, Ngoc L Thai, Tina Y Ko, Khaled Nashar, Richard J Marcus
Kalathil K Sureshkumar, Sabiha M Hussain, Tina Y Ko, Khaled Nashar, Richard J Marcus, Divisions of Nephrology and Hypertension, Department of Medicine, Allegheny General Hospital, Pittsburgh, PA 15212, United States
Ngoc L Thai, Abdominal Transplantation, Allegheny General Hospital, Pittsburgh, PA 15212, United States
Author contributions: Sureshkumar KK participated in research design, performance of the research, data analysis and writing of the manuscript; Hussain SM participated in research design and data analysis; Thai NL participated in research design and data analysis; Ko TY and Nashar K participated in data analysis; Marcus RJ participated in research design, performance of the research and data analysis.
Supported by Health Resources and Services Administration Contract 231-00-0115
Correspondence to: Kalathil K Sureshkumar, MD, FRCP (Glasgow), FASN, Division of Nephrology and Hypertension, Department of Medicine, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212, United States. ksureshk@wpahs.org
Telephone: +1-412-3593319 Fax: +1-412-3594136
Received: March 24, 2014
Revised: June 5, 2014
Accepted: July 25, 2014
Published online: September 24, 2014
Core Tip

Core tip: This study critically looked at outcomes in a large recent cohort of first time deceased donor kidney transplant recipients from the Organ Procurement and Transplant Network/United Network of Organ Sharing database to assess the impact of triple maintenance immunosuppression after receiving various induction therapies. In multivariate analysis, we found an increased risk for death with functioning graft when steroid maintenance was added to calcineurin inhibitor/mycophenolate mofetil based regimen in patients who received powerful induction with rabbit-antithymocyte globulin (r-ATG), an effect that persisted even when patients were split into high and low immune risk groups. Based on these finding we feel that, one has to be cautious while maintaining intense immunosuppression by adding steroid to a calcineurin inhibitor/mycophenolate mofetil regimen in kidney transplant recipients who were selected for r-ATG induction.